STEM CELL REP:烟酰胺可缓解纤维化眼病及视力丧失

2020-04-07 MedSci原创 MedSci原创

支持神经视网膜的视网膜色素上皮(RPE)可以经历EMT,产生纤维状上皮膜(ERMs),与视力受损的临床症状相关,如黄斑皱褶和增殖性玻璃体视网膜病变(PVR)。

上皮细胞向间质过渡(EMT)是一种参与组织形态发生和疾病的生物学过程,会引起细胞形态、迁移、增殖和基因表达的巨大变化。

支持神经视网膜的视网膜色素上皮(RPE)可以经历EMT,产生纤维状上皮膜(ERMs),与视力受损的临床症状相关,如黄斑皱褶和增殖性玻璃体视网膜病变(PVR)。

最近,研究人员发现,TGF-β和TNF-α(TNT)共同处理会加速成人RPE干细胞衍生的RPE细胞培养物中的EMT。研究人员捕捉到了TNT处理RPE引起的全局性表观组和转录的变化,并确定了与活性转录基因相关的活性增强子,包括一组上调的转录因子,这些转录因子是候选调控因子。

研究人员发现,维生素B衍生物烟酰胺可下调这些关键的转录变化,并抑制和部分逆转RPE EMT,揭示了潜在的治疗途径,使ERM、黄斑褶皱和PVR患者受益。

 

原始出处:

Nathan C. Boles et al. Epigenomic and Transcriptomic Changes During Human RPE EMT in a Stem Cell Model of Epiretinal Membrane Pathogenesis and Prevention by Nicotinamide, Stem Cell Reports (2020). DOI: 10.1016/j.stemcr.2020.03.009

 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1794723, encodeId=1a6e1e94723d0, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Jul 09 02:19:24 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871660, encodeId=aa3c18e166046, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Mar 17 08:19:24 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961954, encodeId=a110196195497, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Feb 03 01:19:24 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381991, encodeId=07ac381991e2, content=辛苦分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hjaqgYIPuyYnlKHuyVccZyy7RDOrnqhyrYp2oy3S2NcC7TOa6Qnn2WOuuiacBibVCNNPH7dEAeEpQu9OgBwrzziag/132, createdBy=f9a55320886, createdName=期刊杂志小干gqVSzyq, createdTime=Tue Apr 21 09:47:20 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482294, encodeId=6ab214822948d, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540526, encodeId=0259154052683, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72786, encryptionId=fbbce2786cc, topicName=眼病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85c13256921, createdName=pps20023, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600756, encodeId=35d91600e560c, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1794723, encodeId=1a6e1e94723d0, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Jul 09 02:19:24 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871660, encodeId=aa3c18e166046, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Mar 17 08:19:24 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961954, encodeId=a110196195497, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Feb 03 01:19:24 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381991, encodeId=07ac381991e2, content=辛苦分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hjaqgYIPuyYnlKHuyVccZyy7RDOrnqhyrYp2oy3S2NcC7TOa6Qnn2WOuuiacBibVCNNPH7dEAeEpQu9OgBwrzziag/132, createdBy=f9a55320886, createdName=期刊杂志小干gqVSzyq, createdTime=Tue Apr 21 09:47:20 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482294, encodeId=6ab214822948d, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540526, encodeId=0259154052683, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72786, encryptionId=fbbce2786cc, topicName=眼病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85c13256921, createdName=pps20023, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600756, encodeId=35d91600e560c, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1794723, encodeId=1a6e1e94723d0, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Jul 09 02:19:24 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871660, encodeId=aa3c18e166046, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Mar 17 08:19:24 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961954, encodeId=a110196195497, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Feb 03 01:19:24 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381991, encodeId=07ac381991e2, content=辛苦分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hjaqgYIPuyYnlKHuyVccZyy7RDOrnqhyrYp2oy3S2NcC7TOa6Qnn2WOuuiacBibVCNNPH7dEAeEpQu9OgBwrzziag/132, createdBy=f9a55320886, createdName=期刊杂志小干gqVSzyq, createdTime=Tue Apr 21 09:47:20 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482294, encodeId=6ab214822948d, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540526, encodeId=0259154052683, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72786, encryptionId=fbbce2786cc, topicName=眼病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85c13256921, createdName=pps20023, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600756, encodeId=35d91600e560c, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=)]
    2021-02-03 docwu2019
  4. [GetPortalCommentsPageByObjectIdResponse(id=1794723, encodeId=1a6e1e94723d0, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Jul 09 02:19:24 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871660, encodeId=aa3c18e166046, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Mar 17 08:19:24 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961954, encodeId=a110196195497, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Feb 03 01:19:24 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381991, encodeId=07ac381991e2, content=辛苦分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hjaqgYIPuyYnlKHuyVccZyy7RDOrnqhyrYp2oy3S2NcC7TOa6Qnn2WOuuiacBibVCNNPH7dEAeEpQu9OgBwrzziag/132, createdBy=f9a55320886, createdName=期刊杂志小干gqVSzyq, createdTime=Tue Apr 21 09:47:20 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482294, encodeId=6ab214822948d, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540526, encodeId=0259154052683, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72786, encryptionId=fbbce2786cc, topicName=眼病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85c13256921, createdName=pps20023, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600756, encodeId=35d91600e560c, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=)]
    2020-04-21 期刊杂志小干gqVSzyq

    辛苦分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1794723, encodeId=1a6e1e94723d0, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Jul 09 02:19:24 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871660, encodeId=aa3c18e166046, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Mar 17 08:19:24 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961954, encodeId=a110196195497, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Feb 03 01:19:24 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381991, encodeId=07ac381991e2, content=辛苦分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hjaqgYIPuyYnlKHuyVccZyy7RDOrnqhyrYp2oy3S2NcC7TOa6Qnn2WOuuiacBibVCNNPH7dEAeEpQu9OgBwrzziag/132, createdBy=f9a55320886, createdName=期刊杂志小干gqVSzyq, createdTime=Tue Apr 21 09:47:20 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482294, encodeId=6ab214822948d, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540526, encodeId=0259154052683, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72786, encryptionId=fbbce2786cc, topicName=眼病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85c13256921, createdName=pps20023, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600756, encodeId=35d91600e560c, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1794723, encodeId=1a6e1e94723d0, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Jul 09 02:19:24 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871660, encodeId=aa3c18e166046, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Mar 17 08:19:24 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961954, encodeId=a110196195497, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Feb 03 01:19:24 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381991, encodeId=07ac381991e2, content=辛苦分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hjaqgYIPuyYnlKHuyVccZyy7RDOrnqhyrYp2oy3S2NcC7TOa6Qnn2WOuuiacBibVCNNPH7dEAeEpQu9OgBwrzziag/132, createdBy=f9a55320886, createdName=期刊杂志小干gqVSzyq, createdTime=Tue Apr 21 09:47:20 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482294, encodeId=6ab214822948d, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540526, encodeId=0259154052683, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72786, encryptionId=fbbce2786cc, topicName=眼病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85c13256921, createdName=pps20023, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600756, encodeId=35d91600e560c, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=)]
    2020-04-09 pps20023
  7. [GetPortalCommentsPageByObjectIdResponse(id=1794723, encodeId=1a6e1e94723d0, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Thu Jul 09 02:19:24 CST 2020, time=2020-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871660, encodeId=aa3c18e166046, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Wed Mar 17 08:19:24 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961954, encodeId=a110196195497, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Wed Feb 03 01:19:24 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381991, encodeId=07ac381991e2, content=辛苦分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/hjaqgYIPuyYnlKHuyVccZyy7RDOrnqhyrYp2oy3S2NcC7TOa6Qnn2WOuuiacBibVCNNPH7dEAeEpQu9OgBwrzziag/132, createdBy=f9a55320886, createdName=期刊杂志小干gqVSzyq, createdTime=Tue Apr 21 09:47:20 CST 2020, time=2020-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1482294, encodeId=6ab214822948d, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540526, encodeId=0259154052683, content=<a href='/topic/show?id=fbbce2786cc' target=_blank style='color:#2F92EE;'>#眼病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72786, encryptionId=fbbce2786cc, topicName=眼病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b85c13256921, createdName=pps20023, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600756, encodeId=35d91600e560c, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Thu Apr 09 03:19:24 CST 2020, time=2020-04-09, status=1, ipAttribution=)]

相关资讯

Eye (Lond):为什么是黄斑?

英国伦敦大学学院眼科学院Bird AC近日在Eye (Lond)发表了一篇综述性文章,系统性的介绍了目前关于视网膜中不同区域的视网膜结构和功能的关系,并对视网膜营养不良症和黄斑等疾病进行了讨论。

Ophthalmologica.:增生性糖尿病视网膜病变玻璃体切除术后黄斑在光学相干断层扫描上的结构变化

近日,来自韩国Sungkyunkwan大学、三星昌原医院眼科系的Shin JP医生及其团队在Ophthalmologica.杂志上发表了他们的最近研究:增生性糖尿病视网膜病变玻璃体切除术后黄斑在光学相干断层扫描上的结构变化。

J AAPOS:单侧贝伐珠单抗治疗对于早产儿视网膜病变的黄斑形态影响!

西澳大利亚西兰大学眼科研究所眼科和视觉科学中心的Clark A近日在J AAPOS杂志上发表了他们近期的一项工作,他们进行了回顾性病例研究,评估了单侧玻璃体内贝伐珠单抗(IVB)治疗在单侧1型早产儿视网膜病变(ROP)中对黄斑厚度和中央凹发育的影响。

Sci Rep:老年中国人进行常规白内障手术前使用光学相干断层扫描评估黄斑状态

南京医科大学附属无锡第二医院眼科的Huang X近日在Sci Rep发表了一项工作,他们对光谱域光学相干断层扫描(SD-OCT)在进行常规白内障手术患者术前隐匿性黄斑病变的识别能力进行了研究。

Rom J Ophthalmol:黄斑serporinous 脉络膜炎病例报告

罗马尼亚布加勒斯特儿童急救医院的Cozubas R和急救医院眼科的Ungureanu E等人,在Rom J Ophthalmol杂志上发表了一篇重要的病例报告,他们报告了一例黄斑serporinous 脉络膜炎病例,并对其诊断和治疗进行了讨论。